Inclusion criteria:
Patients who are more than or equal to 18 years old
Patients who have been diagnosed with diabetes for 10 years and more
Patients who have Diabetic Peripheral Neuropathy (DPN) of more than 5 on Toronto Clinical neuropathy score (TCNS)
Patients with Type-1 and Type-2 Diabetes Mellitus
Exclusion criteria:
Patients with score of 5 and less than in TCNS scale
Patients who have Chemotherapy-Induced Peripheral Neuropathy
Patients with foot gangrene
Patients with amputated right or left foot
Patients who refused to participate in the study
Patients with paralysis, partly or entirely unable to move the affected parts of the body
patients with osteoarthritis and osteomyelitis, rheumatoid arthritis
Patient with certain viral or bacterial infections, including Lyme disease, shingles, Epstein-Barr virus, hepatitis B and C, leprosy, Diphtheria, and HIV)
Patients who are receiving any physiotherapy intervention
Patients with inherited disorders, such as Charcot-Marie-Tooth disease are hereditary types of neuropathy;
Patients with autoimmune diseases, include lupus, Guillain-Barre syndrome, demyelinating polyneuropathy and vasculitis
Patients with bone marrow disorders, These include Multiple myeloma, lymphoma and amyloidosis
Patients with other diseases, include kidney and liver disease, connective tissue disorders and hypothyroidism)